Merged unstructured EMR + structured data via NorstellaLinQ to detect disease-screening patterns

Unnamed (global pharma) merged unstructured EMR + structured data via NorstellaLinQ to detect disease-screening patterns — the customer is anonymised in the vendor’s own case study, not withheld by us.

Norstella is a holding company merging several pharma-intelligence brands — Citeline (trial intelligence), Evaluate (forecasting), MMIT (payer/formulary data) and Panalgo (real-world analytics) — into one data asset.

This sits in the Data Providers stage of the AI use-case lifecycle: Named examples from the real-world-data, claims and competitive-intelligence providers pharma AI systems are trained on, benchmarked against, or run inside of.